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Background: Available evidence in Ghana shows the implementation of tuberculosis (TB) control activities efforts
since the beginning of the 1900s. In spite of that, TB continues to be one of the common diseases in the country.
In 1994, local and international policy windows opened for renewed strategies for the control of TB. This paper
explores some of the approaches which have been in place since 1994 and their implications for treatment
outcomes.
Methods: The study combines quantitative and qualitative data. The quantitative data consist of treatment
outcome from 1997–2010 and the qualitative data are derived from in-depth interviews with some staff of the TB
control programme. Poisson regression and inductive coding were applied to the quantitative and qualitative data
respectively.
Results: Reported cure rates increased from 43.6% to 87.7% between 1997 and 2010. The data from the in-depth
interviews (IDIs) suggested that improvements in diagnosis, community TB care, stigma reduction among
community and health workers towards TB patients, the public-private partnership, and the enablers’ package
contributed to the improved better treatment outcomes, particularly from 2008.
Conclusions: Lessons learnt include the achievement of objectives with varying strategies and stakeholder
interventions. Further studies would be needed to quantify the contributions of the various interventions to help
determine those that are cost effective as well as efficient and effective for TB control.
Keywords: Tuberculosis control, Diagnosis, Treatment outcomesBackground
As part of the measures to reduce, if not eliminate, the
adverse effects of TB, a number of interventions and
strategies have been applied, from the individual, soci-
etal, national and international levels since the disease
was first identified in the 1800s [1]. At the individual
level, various strategies have been adopted, for instance
“purging, bed rest, horseback riding, the mountains, the
seashore, cod-liver oil, castor oil, phrenic nerve interrup-
tion, thoracoplasty, pneumothorax, lucite ball, air in the
chest, air in the abdomen … the list of attempted reme-
dies from the Greeks to the moderns (sic) seems nearly
infinite” ([2], p.11).
The provision of sanatoria was also seen as one of
the effective broad scale approaches to controlling TB* Correspondence: kjamoadjei@yahoo.com
Department of Population and Health, University of Cape Coast, Cape Coast,
Ghana
© 2013 Amo-Adjei and Awusabo-Asare; licens
terms of the Creative Commons Attribution L
use, distribution, and reproduction in any medinfection and cure [3]. Others were public health inter-
ventions such as mass screening and vaccinations, which
have been claimed to contribute to reducing TB infec-
tions [4,5] and at the societal level, the implementation
of poverty reduction strategies in some parts of the
world, especially the developed countries [6,7].
The body of knowledge on factors contributing to the
decline in the TB infections and death have been diverse
and sometimes saddled with controversies, especially
those, which deal with interventions prior to the devel-
opment of chemotherapy. For instance, McKeown [8]
has emphasised the contribution of improved nutrition
to the decline of TB, while Szreter [9] has argued around
the impacts of broad social interventions such as legisla-
tions against overcrowding at residential and industrial
areas as factors which accounted for the decline of TB
in some parts of Europe.ee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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also accounted for improved diagnosis and treatment of
TB. For instance, the reduction in treatment duration
from 18 months to six months [10] is considered to have
led to improvement in compliance to treatment and subse-
quently low defaulter rates. Similarly, other measures such
as fixed-dose combination [11], community treatment care
[12], enablers package [13], standardised treatment [14],
the establishment of Green Light Committee (GLC) and
Global Drug Facility to facilitate reliable drug supply [15],
practical approach to lung disease (PAL) [16], and public
private partnership [17] have been introduced with the
objective of reducing the burden of TB on individuals
and communities.
In Ghana, attempts to deal with TB dates back to the
early 1900s. However, those attempts were sporadic and
uncoordinated. Formalised institution for TB control
came into being in 1959 with the establishment of the
Ghana TB Services [18]. However, towards the end of
the 1960s through to the early 1990s, activities geared
towards the control of the disease declined substantially
[19]. The HIV/AIDS epidemic, which became prominent
around the world in the early 1990s heightened and
increased re-emergence of TB led to renewed interest in
TB control at the international level, also led to change
in strategies and policies in the country.
For instance, with the increasing burden of TB, partly
fuelled by HIV/AIDS epidemic, the WHO, in 1993,
declared TB a global emergency, calling for new efforts
and commitments for control of the disease. Country
health departments/ministries were called upon to for-
malise and establish national response programmes. In
response to such calls, Ghana established a new TB control
programme in 1994.
Despite the fact that Ghana is not one of the high
burden TB countries in Africa, it nevertheless considers
TB as an important health challenge. Together with
HIV, they account for about 7% of all deaths, the second
after malaria [20]. It is also estimated that less than half
of TB in the country are notified. For example, in 2010,
only 15,145 of the 47,632 projected cases were diagnosed
[20].
This paper tracks TB treatment outcomes in the coun-
try and explores possible social and biomedical interven-
tions which are perceived to have contributed to the
fight against the disease in Ghana. The aim is to identify
the social and technical strategies which have been
implemented since 1994, and their implications for TB
diagnosis and treatment outcomes.
Methods
This paper was extracted from a larger study which
investigated policy environment for TB control in Ghana.
Among the issues examined in the larger study werehistorical perspectives on the disease, public-private
partnership, integration of TB and HIV control program-
mes, and obstacles and opportunities for TB control
interventions.
This study combined quantitative and qualitative
methods, leading to a mixed method approach [21]. The
quantitative data are treatment outcomes, available from
1997 to 2010 from the National Tuberculosis Control
Programme (NTP). The data were collected through pas-
sive surveillance and are disaggregated by region and
the two tertiary hospitals in the country, the Korle-Bu
Teaching Hospital (KABTH) and the Komfo Anokye
Teaching Hospital (KATH). The treatment outcome infor-
mation available in the data set is the number of people
cured, completed treatment, died, treatment failure, and
defaulters. A TB case is categorized as cured when a pa-
tient completes all prescribed doses and is documented to
have recorded two or more consecutive negative cultures
after six months of starting treatment. Treatment comple-
tion occurs when all prescribed doses are adhered to but
lacking bacteriologic proof of cure because a patient is un-
able to produce sputum. Death occurs if during the treat-
ment period, the patient dies with TB as the major cause
of death, or death arising from toxicity due to anti-TB
medications after receiving at least one week of anti-TB
medications. Treatment is categorized as a ‘failure’ if there
is presence of positive culture for M. tuberculosis after
four months of treatment. Treatment default is when
treatment is interrupted for two or more consecutive
months after initiation of treatment. Because the treat-
ment outcome data were captured as count data, Poisson
regression was used to analyse the treatment outcomes
data. This was chosen because, first, the data did not con-
tain any zeros to warrant the application of Zero-inflated
and also, the data did not show evidence of dispersion to
permit the use of Negative binomial regression. Simple
linear regression will also not be applicable in this case be-
cause the data was not collected through random sampling.
The results are presented in incident rate ratio (IRR).
The qualitative data was collected from national,
regional, district and health facility TB coordinators and
service providers. At the national level, three senior
programme officers were interviewed, two of whom had
been with the programme since 1994 and thus were able
to provide detailed information about the programme.
In addition to the national officers, four regional TB
coordinators were selected based on the recorded TB
case notifications in these regions. In each of the regions
selected, the district with the highest notification rate of
TB was chosen and the district coordinators (4) included
in the study. In each district, three facilities (2 public
and 1 private), and TB coordinators were interviewed.
Finally, one respondent who works with a TB-related
international NGO was also interviewed, resulting in
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dents constitute a sub-sample of a total of 31 respon-
dents in the larger study). Semi-structured interview
guide used covered issues in TB control such as political
commitment, public-private partnership, integration of
TB and HIV services and sustainability current interven-
tions. All the interviews were tape-recorded, transcribed
and analysed manually. The qualitative data analysis plan
followed an inductive approach as reported elsewhere
[22]. The University of Cape Coast Institutional Review
Board reviewed, and gave ethical approval for the study.
Results
Results of the study are reported in two sections: first is
analysis of TB treatment outcomes based on the quanti-
tative data and the second deals with perceived factors
which may have contributed to the observed results
using the qualitative data.
TB treatment outcomes: 1997 – 2010
Regardless of the number of reported TB cases in a
setting, key treatment outcomes are expected to improve
in line with WHO treatment outcomes benchmarks.
Currently, international benchmark for assessing coun-
tries’ performance in respect of cure rates is 85%.
Figure 1 shows the proportion of patients who were
cured between 1997 and 2010 ranged from 44% in 1997
to 87% in 2010. Cure rates for the first decade of TB
surveillance were below the WHO thresholds of 85 per
cent but improvements are noted from 2008 onwards.
While there was increase in the cure rates, the propor-














































Figure 1 Proportion of TB patients cured successfully between 1997–declined. The Poisson regression outputs confirming
these are shown in Table 1. The overall likelihood of cure
was significantly highest in the Greater Accra (IRR =
1.359; p < 0.001) while the least incident rate ratio of cure
was reported at the Komfo-Anokye Teaching Hospital
[KATH] (IRR = 0.00991; p < 0.001). [The Western Region
was used as the reference category because it reported
one of the highest TB rates in the country]. Completed
treatment was more likely in the Western compared to
the others. TB deaths were more likely in the Eastern Re-
gion, approximately 55% compared to the Western Re-
gion. The rate of treatment failure was significantly lower
in the Upper West Region.
Treatment outcomes varied by year of surveillance: the
rate ratio of cure and treatment failure was lowest in
2009 and treatment completion was higher in 2010 than
any of the earlier periods. The rate of TB death was
significantly more likely in 1998, 2003, 2005 and 2006.
Default in treatment was less likely in 2008. In respect of
overall default, outstanding results are observed after
2006 (Table 1).
When decomposed by region and year (data not
shown) and we found that in 2009, the likelihood of cure
was significantly more likely in the Northern Region in
2009 (using 1997 as the base year) while the least cure
rates were reported at the Korle-Bu Teaching Hospital
for the years 2006, 2008 and 2009.
Qualitative evidence
Background of respondents and themes
The number of years of experience of the respondents















Table 1 Tuberculosis treatment outcomes by region and surveillance year in Ghana, 1997-2010
Observations Cure Completed Died Failure Default
IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
Central1 0.990 [0.960,1.020] 0.438*** [0.399,0.480] 1.376*** [1.256,1.508] 0.842* [0.723,0.979] 1.714*** [1.618,1.816]
Greater Accra 1.359*** [1.321,1.399] 0.393*** [0.357,0.432] 1.061 [0.962,1.169] 0.689*** [0.586,0.808] 0.819*** [0.765,0.877]
Volta 0.828*** [0.802,0.855] 0.494*** [0.452,0.540] 0.903* [0.816,0.999] 0.350*** [0.286,0.428] 0.417*** [0.383,0.454]
Eastern 0.970* [0.940,1.000] 0.631*** [0.581,0.685] 1.545*** [1.413,1.689] 0.702*** [0.599,0.824] 1.002 [0.939,1.069]
Ashanti 1.215*** [1.180,1.251] 0.939 [0.873,1.011] 1.315*** [1.199,1.442] 0.391*** [0.322,0.474] 0.526*** [0.486,0.569]
Brong-Ahafo 0.470*** [0.452,0.488] 0.416*** [0.378,0.457] 1.011 [0.917,1.116] 0.571*** [0.482,0.677] 0.351*** [0.321,0.384]
Northern 0.230*** [0.219,0.242] 0.247*** [0.219,0.278] 0.334*** [0.290,0.386] 0.165*** [0.124,0.220] 0.162*** [0.142,0.184]
Upper East 0.243*** [0.232,0.256] 0.0946*** [0.0795,0.113] 0.579*** [0.516,0.649] 0.139*** [0.104,0.187] 0.114*** [0.0985,0.131]
Upper West 0.0973*** [0.0905,0.105] 0.168*** [0.147,0.192] 0.267*** [0.230,0.311] 0.0929*** [0.0654,0.13] 0.0802*** [0.0677,0.0949]
KATH 0.00991*** [0.0079,0.0123] 0.296*** [0.266,0.330] 0.127*** [0.104,0.157] 1.049 [0.909,1.211] 0.0681*** [0.0568,0.0817]
KBTH 0.0145*** [0.0121,0.0174] 0.287*** [0.257,0.319] 0.209*** [0.177,0.247] 0.926 [0.799,1.074] 0.120*** [0.104,0.138]
19982 1.287*** [1.222,1.356] 0.861* [0.765,0.969] 1.046 [0.933,1.173] 0.798** [0.675,0.945] 0.886** [0.822,0.955]
1999 1.234*** [1.171,1.301] 0.728*** [0.644,0.824] 0.872* [0.773,0.983] 0.921 [0.783,1.083] 0.818*** [0.758,0.883]
2000 1.181*** [1.120,1.245] 0.679*** [0.599,0.770] 0.788*** [0.697,0.891] 0.743*** [0.626,0.883] 0.671*** [0.619,0.728]
2001 1.327*** [1.260,1.397] 1.113 [0.996,1.243] 0.803*** [0.711,0.908] 0.766** [0.646,0.908] 0.867*** [0.804,0.934]
2002 1.525*** [1.450,1.604] 0.786*** [0.696,0.887] 0.937 [0.833,1.053] 0.663*** [0.555,0.791] 0.731*** [0.676,0.791]
2003 1.695*** [1.613,1.781] 0.866* [0.770,0.974] 1.024 [0.913,1.149] 0.498*** [0.410,0.604] 0.711*** [0.657,0.770]
2004 1.724*** [1.641,1.811] 0.971 [0.866,1.088] 0.942 [0.837,1.059] 0.495*** [0.407,0.601] 0.647*** [0.596,0.702]
2005 1.921*** [1.830,2.016] 0.751*** [0.665,0.849] 1.092 [0.975,1.223] 0.478*** [0.393,0.582] 0.579*** [0.532,0.630]
2006 2.052*** [1.956,2.152] 0.822** [0.729,0.926] 1.092 [0.975,1.223] 0.501*** [0.413,0.608] 0.326*** [0.294,0.361]
2007 2.145*** [2.046,2.250] 0.930 [0.828,1.044] 0.981 [0.873,1.102] 0.352*** [0.283,0.439] 0.153*** [0.133,0.176]
2008 2.324*** [2.218,2.436] 1.062 [0.950,1.188] 0.885* [0.786,0.997] 0.346*** [0.277,0.431] 0.123*** [0.106,0.144]
2009 2.496*** [2.382,2.615] 1.139* [1.020,1.272] 0.846** [0.750,0.955] 0.281*** [0.222,0.357] 0.152*** [0.132,0.175]
2010 2.206*** [2.104,2.313] 1.285*** [1.154,1.430] 0.877* [0.778,0.988] 0.339*** [0.272,0.424] 0.163*** [0.142,0.186]
Constant 343.2*** [328.3,358.7] 113.1*** [103.0,124.1] 60.15*** [54.13,66.84] 44.73*** [38.61,51.82] 232.7*** [217.7,248.7]
Log likelihood −2172.6 −1052.5 −910.9 −735.6 −1435.3
Chi-squared 47983.4 2994.5 3028.6 1306.1 13179.8
N 167 167 167 167 167
p < 0.05, ** p < 0.01, *** p < 0.001.
Reference groups are as follows: 1Western; 21997.
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from 2–15 years. The national officers and few regional
personnel had been involved in TB control longer than
the others, especially compared to those at the facilities.
At the facility levels, there were indications of attrition
due to regular postings. The conversation with the
respondents revolved around factors contributing to the
trend in the number of TB cases identified and the
corresponding treatment outcomes. Depending on expe-
rience and the duration respondent had been involved in
TB control; views on determinants of the treatment
outcomes were diverse. The qualitative data collection
was partly used to document perceptions on the mana-
gement and outcomes of the various strategies which
had been adopted since 1994. The following themeswere extracted from the interviews: improvement in case
management; improved diagnosis; the introduction of
community TB care and enablers’ package, stigmatisa-
tion of TB patients, interest of health personnel in TB
management, and the involvement of private sector in
TB control.
Improved TB case management
Respondents were of the view that improvement had
occurred in case management and this was reflected in
treatment outcomes, for example, cure and default rates.
The respondents generally believed that more patients
were now complying with treatment regimens than
before. A low defaulter rate is beneficial to the individual
patient as well as the larger health system as defaulting
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following excerpt from a respondent demonstrates how
declining default rates is viewed:
What I consider to be a major outcome of the new
strategy is the reduction in defaulter rates. I learnt
that defaulter rates in the region were around 20% in
the past but presently; it has reduced to around 4-5%
(Coordinator, Region 1).
The most prominent reason respondents gave for the
decline in default rates was the introduction of a fixed
dose combination therapy, which has reduced the treat-
ment period to standardised six months, which hitherto,
ranged from eight to 18 months. Fixed-dose combin-
ation (FDC) is a condensation of first-line drugs:
ethanbutol, isoniazid, rifampicin and pyrazinamide into
one dosage [24]. FDC can reduce the risk of incorrect
dosage, simplify drug procurement and improves adher-
ence [11]. Thus, it was noted that:
… The result of the cutting down on treatment period
from eight to six months for non-resistant TB has
improved completion rate and subsequently, cure
rates. Previously, the long duration for treatment led
to more defaulters (Region 2 Coordinator).
Improvements in technology which led to decline in
the duration of administration of the drugs appears to
have translated into adherence to drug regimens.
Improvement in diagnosis
Improvement in the diagnosis of suspected TB patients
was also considered to be one of the important compo-
nents of the TB control programme. To them, early and
accurate diagnosis of suspected cases made it possible for
treatment to start early. Because a single TB patient could
transmit the disease to about 10 persons per annum, the
identification of even one case at its early stage was
important to reducing new infections. A respondent had
this to say about improved diagnosis:
We have ensured that the quality of sputum
produced for diagnosis is appreciable because
confirmation of cases is difficult or impossible
without laboratory confirmation. In line with this,
every patient is given two containers for sputum
specimen – one for early morning specimen and
other for on-the-spot specimen. We observed
from this initiative that the quality of sputum
improved … after implementing coaching of
suspects, there were slight changes, about 2% in
quality of sputum and we expect this to continue
improving … quality sputum allows us to haveproper bacilli formation through culturing
(Region I, Laboratory Focal Person).
It has been reported that poor diagnosis was a major
hindrance to TB control because imprecise diagnosis
could result in false negative results. The provision of
information on reasons for the collection of sputum, how
to produce the sputum; information on characteristics of
quality sputum have had impacts on the quality of spu-
tum, leading to positive sputum microscopy analysis [25].
Community TB treatment care
One of the elements of the new approach to TB treat-
ment is the participation of community members. The
community treatment care concept recognises social
capital and connectedness as instrumental to effective TB
control. Under this intervention, individual TB patients
are assigned a “significant other” to motivate and super-
vise patients to take his/her drugs. Health workers in
collaboration with patients do the selection of treatment
supporters. Some respondents were of the view that
community involvement had played a very important role
in improving treatment completion and helped to reduce
defaulter rates. As noted by one of the respondents:
Community involvement has helped to reduce
defaulter rates because some selected individuals
within patients’ immediate environment help to
supervise treatment without necessarily travelling
long distances for treatment (Region 2 Coordinator).
To some of the respondents, the use of treatment
supporters who could be family members, religious
leaders, health workers or other gatekeepers who the
patient trusts and feel comfortable dealing with might
have contributed to the improved adherence to treatment.
Decline in stigma and response of health personnel to TB
management
The available evidence suggests that stigma of infected
people and the affected poses some amount of threat to
effective TB control [26]. Stigma may discourage infected
persons from seeking treatment early. One of the stra-
tegies was to engage communities in stigma reduction
programmes. Even among nurses, it was considered a
punishment to be transferred to the chest clinic but this is
changing [25]. A senior national officer noted that the
changes in health workers attitudes, in particular are con-
tributing positively to stigma reduction and the overall
management of the disease. He noted:
Now even the cadres of health worker coming in are
people who have opted to work with the TB control
programme. Previously, it was considered a
Amo-Adjei and Awusabo-Asare Archives of Public Health 2013, 71:22 Page 6 of 8
http://www.archpublichealth.com/content/71/1/22punishment to be posted to chest clinic. Personnel
who were considered stubborn, indiscipline or rebels
in the system were sent to DOTS centres –
it was like Siberia. But that is changing. There is
increasing commitment from health workers to be
involved in TB control and this is helping a lot
(National Officer, A).
Another respondent at the regional level also expressed
satisfaction with the changing attitude of health workers
towards TB control.
It was a disease people did not want to get closer to;
if you were in the chest clinic, even your colleagues
were not willing to come close to you. But now,
people feel comfortable working with TB patients.
Although resources in TB may be a factor, the
important thing is that some health workers have
gone through training programmes to work with TB
patients. Through these training programmes, we
have been able to demystify people’s perception that
TB is a dangerous (District Coordinator, Region 2).
Funded disease control programmes such as TB, HIV/
AIDS and Malaria tend to attract personnel, apparently,
because of the financial resources associated with those
programmes. Although the respondents were aware of
the resources involved in TB control, their interests
could not be attributed to the resources. Another reason
respondents cited, as accounting for the changes in the
attitude of health workers was the positive treatment
outcomes being recorded – the perception that staff at
the facilities are seeing results from their labours has
given some of them further impetus to continue. As
observed by one respondent:
People see a clear vision for TB control, knowledge
has improved, there is greater understanding, the
disease has been demystified, logistics needed for
control are available – workers don’t have to shout
and shout for resources … health workers are
beginning to see results, which translate into job
satisfaction. If you treat somebody and notice the
patient is getting healed, you become content
(National Officer A).
The claims by some of the senior management of the
NTP at the national and regional levels were colla-
borated by personnel who were directly dealing with
patients. Generally, the respondents at the health facil-
ities confirmed the views expressed by the top manage-
ment as many of them indicated that they willingly
accepted postings to DOTS centres. Their argument was
that it was professionally ethical for a health worker toaccept to work on categories of patients without prejudice
and discrimination.
I accepted to come here because I have been trained
to provide health care to all those who need it,
regardless of their condition. There was no reason
for me to refuse posting to the DOTS centre
(DOTS Centre Nurse, Region 2, Public Hospital).
The enablers’ package
An enablers’ package include a wide range of services
such as travel vouchers, reimbursement, cash payments,
toiletries, clothing, cell phone minutes, food during
DOT visits, vouchers, periodic food packages; social wel-
fare payments during treatment; income generation pro-
ject; salary payments, legal services, housing or housing
subsidies, personalised incentives or “bait for fishermen”
(providing other payments to community or patients
who bring suspects for treatment) [27]. Cash payments
or travel vouchers (both staff and clients), food supple-
ments/packages and social welfare payments are some of
the popular enablers’ support in Ghana. One respondent
described how she felt about the enablers’ package in
the following extract:
Among the poorest of clients, they were
given transportation, beverages and then home
support visit … The enablers’ package was an
encouragement factor; people came because
their relations had told them to do so due
to enablers’. This pushed people with
chest/lung ailments to come on their own
accord due to that small token.
The enablers package also covered travel vouchers for
health workers and this, according some respondents, it
facilitated home verification, etc.
Public-private partnership
Public-private partnership (PPP) for TB control is
important of its effects on bridging access gaps [28]. A
section of the respondents felt that the PPP has made
modest contributions to TB control in Ghana, although
there is no disaggregated data on TB treatment outcome
by type of facility [19]. In the view of the respondents,
the PPP approach has the potential of improving access.
A respondent in one of the regions where the PPP was
piloted had this to say:
It worked well in the few places where it was first
started. We are able to manage many patients who
could have been lost to follow-up, given that there are
only five public hospitals in this metropolis providing
DOTS services. At one point, we were recording no
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facility was involved in DOTS, even maternity homes
(Coordinator, Region 2).
Discussion
This paper has offered some insights about TB treat-
ment outcomes in Ghana between 1997 and 2010.
Coupled with that, attempts have been made to explore
the views of key personnel involved in TB control about
the possible patient and health system-based factors
which have played important roles in achieving the
current treatment outcomes. In spite of the modest
contributions of this study to our understanding of TB
treatment outcomes and the possible factors shaping
these outcomes, we are limited to make attributions.
However, the findings shed light on possible inter-
ventions and strategies which could be studied further
to ascertain their measureable impacts on TB control in
Ghana. The qualitative evidence is also not representa-
tive of the whole NTP establishment.
Importantly, our results point to incremental impro-
vements in five specific TB treatment outcomes: the rate
of cure, completed treatment, treatment failure, default
and death from TB. The timing (year) and places (region)
where the best results were achieved on each of the treat-
ment outcomes varied significantly. However, in 2009, im-
pressive results were achieved on all outcome measures.
Follow-up discussions at the headquarters of the NTP
revealed that in 2009, there was high participation of TB
related-NGOs in advocacy on the need for testing, early
treatment seeking and other equally important compo-
nents of TB management.
Of comment, another relevant finding, is the high like-
lihood of TB deaths in the Eastern Region. The Eastern
Region of Ghana has consistently recorded the highest
burden of HIV [29]. HIV infection does not only reacti-
vate latent TB infection but also accelerates new infections
and re–infections, with a lifetime risk of TB occurring
among HIV patients ranging from 10–20% [30]. Without
timely initiation of joint TB and HIV treatment, the like-
lihood of TB mortality could be significantly higher. The
HIV situation in the Eastern Region may therefore be a
contributory factor the high likelihood of TB mortality in
the region.
The results further point to poor TB treatment out-
comes at the two tertiary hospitals, particularly, the
Korle-Bu Teaching Hospital. Whereas a number of
factors may be contributing to the outcomes at the
tertiary hospitals, few are hypothesised. First, as some
respondents recounted, community treatment care and
regular follow-ups on patients have been critical to treat-
ment outcomes. However, because these hospitals are
referral and also located in cosmopolitan areas, follow-up
on patients may not be effective and efficient as it possiblyhappens at the lower levels of health delivery. Further stud-
ies that compare the quality of care at tertiary hospitals on
the one hand and lower level hospitals/clinics on the other
hand may help us get better understanding of these issues.
Adherence to TB treatment is an important conside-
ration in TB control programs because incomplete treat-
ment can lead to prolonged infection, drug resistance,
relapse, and death [13]. The enablers’ package, an inter-
vention, which seeks to motivate patients and health
workers, highlighted as a factor in improving treatment
outcomes. This finding re-enforces the relevance of the
package, especially the fact that it is health workers who
are highlighting on its importance. Much of the evidence
on the usefulness of the enablers’ package has come
from patient beneficiaries.
It was also noticed that the increasing interest of
health workers in TB control efforts is not arising from
the amount of financial resources available to the TB
programme, although an earlier study on barriers to the
control of TB had revealed monetary incentives as one
of the barriers [22]. According to this study, the financial
resources in the TB control programme had unfortu-
nately led to “personalisation” of activities by some TB
coordinators. Financial motivations for health personnel
on programmed diseases can be counter-productive
[31]. Some part of the existing evidence suggests that as
long as there are funds, such diseases are attractive to
many personnel. For instance, In Burkina Faso, it was
found that the interest of health workers in HIV/AIDS was
far more than the interest in reproductive health [31].
The findings also suggest that a reverse causality
between treatment outcomes and the interest of health
workers in TB control. Some respondents perceived that
with the rising positive outcomes in treatment, health
workers are becoming more committed to TB manage-
ment and this in turn served as the motivation to work
harder. In their review of motivations of health workers,
Dolea and Adams [32] found that non-financial incentives
such as better treatment results served as intrinsic moti-
vation to health workers.
In keeping with earlier studies [17,27,33,34], this study
also highlights the need to up-scale the involvement of the
private sector in TB control. The study participants gene-
rally indicated that the PPP approach has made positive
contribution to TB control. Despite the importance of the
private sector in TB control, sub-standardised DOTS
treatment has been reported [35]. The inclusion of private
sector in TB control therefore requires constant monito-
ring and supervision in order to assure and maintain
standardised treatment.
Conclusions
Overall, the findings can be summarised into two broad
areas: the perceived contributions of social and biomedical
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package, community participation in treatment and the
public-private partnership. The contributions of biomed-
ical interventions were linked to better case management
through the use of FDC and improvement in diagnosis
and confirmation of cases. It appears from the findings
that an effective combination of social and biomedical
interventions may be able to accelerate the global efforts
towards significant improvements in TB control. While
no attempts were made to match the specific inter-
ventions with any particular outcomes due to the explora-
tory nature of the study, it can be concluded that the
interventions mentioned by the respondents (albeit not
exhaustive) were perceived to have contributed to better
treatment outcomes of TB in Ghana. The interventions
noted and other novel ones should be pursued by the
policy makers to help achieve the goals set for TB.
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